FDA fleshes out models for safe continuous manufacture of therapeutic proteins
Regulatory NewsJoanne S. Eglovitch
BiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaQuality Assurance and ControlRegulatory Intelligence/Policy